Key Highlights

  • Cenntro (NASDAQ:CENN) slid 46.02% to USD 0.1607 despite a delivery update, with a USD 100 million share program in place.
  • Parabolic Technologies (NASDAQ:PARA) dropped 24.26% to USD 2.06 after a Nasdaq delisting determination.
  • Baird Medical (NASDAQ:BDMD) declined 18.38% to USD 0.0955, with cash of USD 289,083 at June 30, 2026.
  • 22nd Century Group (NASDAQ:XXII) lost 16.56% to USD 0.0403 ahead of a 1 for 58 reverse split.
  • Mercer International (NASDAQ:MERC) fell 16.23% to USD 0.1776 as a Recapitalization leaves existing holders with about 8.5%.

Cenntro Inc. (NASDAQ:CENN) (down USD 0.1370, 46.02%): Delivery News Meets a Large Share Program

Cenntro (NASDAQ:CENN) was down 46.02% to USD 0.1607 in pre-market trading on November 4, 2026, a decline of USD 0.1370 from the November 3 close. The only announcement identified, dated November 3, covered 20 LS450 electric truck deliveries under a New York voucher program, worth more than USD 2.44 million in Revenue according to the company. That does not explain a sharp fall, so the cause is unconfirmed.

The more relevant disclosure is a sales agreement dated October 9, 2026 allowing up to USD 100 million of common stock to be offered over time. Full year 2025 revenue was USD 18.08 million, down about 42%, with a net loss of about USD 72.98 million. As a penny stock, it faces dilution risk and a possible new Nasdaq deficiency notice.

Parabolic Technologies, Inc. (NASDAQ:PARA) (down USD 0.6598, 24.26%): Nasdaq Hearing Window Closes

Parabolic Technologies (NASDAQ:PARA) fell 24.26% to USD 2.06 in pre-market trading on November 4, 2026, a drop of USD 0.6598 from the November 3 close. No announcement dated November 3 or 4 was identified as a trigger, and no filing confirming a hearing request was found.

According to a filing signed October 30, 2026, Nasdaq issued a delisting determination after the bid stayed under USD 1.00 for 30 consecutive Business days. A hearing request was due by 4:00 p.m. ET on November 3, and without one, trading would be suspended on November 5. Preliminary third quarter revenue was about USD 4.7 million, up 65%, unaudited. Dilution is a risk, since authorized shares were raised to 850,000,000.

Baird Medical Investment Holdings Ltd (NASDAQ:BDMD) (down USD 0.0215, 18.38%): Thin Cash After a China Deal

Baird Medical (NASDAQ:BDMD) declined 18.38% to USD 0.0955 in pre-market trading on November 4, 2026, a fall of USD 0.0215 from an implied close of about USD 0.1170 (calculated). No announcement dated November 3 or 4 was identified. The move may reflect continued selling in a very low priced stock, though that is an inference.

A company release dated November 2 described an exclusive distribution agreement covering 19 China markets, with an initial order of about 6 million Chinese yuan, roughly USD 900,000. First half 2026 revenue rose 24.6% to USD 9.92 million in unaudited results. The risk is liquidity: cash and restricted cash were USD 289,083 at June 30, 2026, against a USD 10.76 million short term Loan balance.

22nd Century Group, Inc (NASDAQ:XXII) (down USD 0.0080, 16.56%): Reverse Split Arrives

22nd Century Group (NASDAQ:XXII) fell 16.56% to USD 0.0403 in pre-market trading on November 4, 2026, a drop of USD 0.0080 from an implied close of about USD 0.0483 (calculated). A filing dated November 3 set a 1 for 58 reverse split effective at 12:01 a.m. Eastern Time on November 5, cutting shares outstanding from 31,949,758 to roughly 550,858.

The split aims to restore Nasdaq Capital Market compliance. Preliminary third quarter revenue from continuing operations was about USD 4.8 million, with a net loss of USD 2.6 million, unaudited and subject to change. The risk is that cash of USD 3.9 million is modest, so financing and dilution remain possible.

Mercer International Inc. (NASDAQ:MERC) (down USD 0.0344, 16.23%): Recapitalization Cancels Existing Shares

Mercer International (NASDAQ:MERC) fell 16.23% to USD 0.1776 in pre-market trading on November 4, 2026, a drop of USD 0.0344 from an implied close of about USD 0.2120 (calculated). The company's November 2 announcement of a recapitalization would swap about USD 1.1 billion of notes for equity, with existing shareholders receiving about 8.5% of new common stock.

The plan would run through a prepackaged Chapter 11 case, due to commence by November 9, 2026. The company expects Nasdaq to issue a delisting notice. Second quarter revenue was USD 460.3 million with a net loss of USD 76.0 million, and third quarter results are scheduled for November 5.

Where Things Stand

All five face Balance Sheet strain. Cenntro has a large share program in place, Parabolic a listing deadline, Baird Medical a thin cash balance, 22nd Century a reverse split and Mercer a restructuring. Track the November 5 events for Parabolic, 22nd Century and Mercer, then the Chapter 11 filing deadline of November 9. Light pre-market Volume means moves can shift at the open.